Top

Journal of Cancer Survivorship

Published in:

01-02-2019 | Fatigue | Review

The effectiveness of mHealth for self-management in improving pain, psychological distress, fatigue, and sleep in cancer survivors: a systematic review

Authors: Elizabeth Hernandez Silva, Sheleigh Lawler, Danette Langbecker

Published in: Journal of Cancer Survivorship | Issue 1/2019

Abstract

Purpose

Integrating mHealth into the cancer care continuum may be an effective strategy to improve cancer survivorship care by supporting self-management. We aim to assess the effectiveness of mHealth applications (apps) for self-management in improving pain, psychological distress, fatigue, or sleep outcomes in adult cancer survivors.

Methods

Experimental quantitative studies evaluating apps aiming to support self-management for adult cancer survivors and reporting pain, psychological distress, fatigue, or sleep outcomes were included. PubMed, Web of Science, Embase, CINAHL, PsycINFO, Scopus, and CENTRAL databases were searched from inception through December 2017. Risk of bias was assessed using the Cochrane risk of bias tool (PROSPERO registration number CRD42017081182).

Results

Seven studies of six mHealth interventions (n = 949 participants) were included. Two randomized controlled trials (RCTs), one quasi-RCT, one non-RCT, and three single-arm studies involved survivors with a mix of cancer types. The most common app features were symptom questionnaires (n = 5) and progress tracking (n = 5). Four studies reported outcomes for pain, with three showing improvements. Two studies reported psychological distress outcomes, showing mixed results. Four studies reported improvements in fatigue post-intervention or in the intervention compared with control group, but the changes were not all statistically significant. Two studies reported improvements in sleep outcomes.

Conclusions

There is emerging evidence that mHealth interventions that support self-management can improve pain and fatigue outcomes in cancer survivors, and some promise for psychological distress and sleep outcomes. Further development and investigation of mHealth is needed, incorporating targeted, evidence-based models of care into app design.

Implications for Cancer Survivors

mHealth interventions can improve outcomes for cancer survivors and have significant potential to benefit this growing population due to their reach.

Available only for authorised users

Statista. Number of smartphone users worldwide from 2014 to 2020. 2018. https://www.statista.com/statistics/330695/number-of-smartphone-users-worldwide/.

Mendiola M, Kalnicki M, Lindenauer S. Valuable features in mobile health apps for patients and consumers: content analysis of apps and user ratings. JMIR mHealth uHealth. 2015;3(2):e40. https://doi.org/10.2196/mhealth.4283. CrossRefPubMedPubMedCentral

Anderson K, Burford O, Emmerton L. Mobile health apps to facilitate self-care: a qualitative study of user experiences. Report. 2016;11(5):e0156164. https://doi.org/10.1371/journal.pone.0156164.CrossRef

Birkhoff SD, Smeltzer SC. Perceptions of smartphone user-centered mobile health tracking apps across various chronic illness populations: an integrative review. J Nurs Scholarsh. 2017;49(4):371–8. https://doi.org/10.1111/jnu.12298.CrossRefPubMed

Davis SW, Oakley-Girvan I. Achieving value in mobile health applications for cancer survivors. J Cancer Surviv. 2017;11(4):498–504. https://doi.org/10.1007/s11764-017-0608-1.CrossRefPubMed

Darlow S, Wen KY. Development testing of mobile health interventions for cancer patient self-management: a review. Health Informatics Journal. 2016;22(3):633–50. https://doi.org/10.1177/1460458215577994.CrossRefPubMed

Bender JL, Yue RYK, To MJ, Deacken L, Jadad AR. A lot of action, but not in the right direction: systematic review and content analysis of smartphone applications for the prevention, detection, and management of cancer. J Med Internet Res. 2013;15(12). https://doi.org/10.2196/jmir.2661.

Aaronson NK, Mattioli V, Minton O, Weis J, Johansen C, Dalton SO, et al. Beyond treatment - psychosocial and behavioural issues in cancer survivorship research and practice. EJC Suppl. 2014;12(1):54–64. https://doi.org/10.1016/j.ejcsup.2014.03.005.CrossRefPubMedPubMedCentral

Pachman DR, Barton DL, Swetz KM, Loprinzi CL. Troublesome symptoms in cancer survivors: fatigue, insomnia, neuropathy, and pain. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30(30):3687–96. https://doi.org/10.1200/JCO.2012.41.7238. CrossRef

10.

Prue G, Rankin J, Allen J, Gracey J, Cramp F. Cancer-related fatigue: a critical appraisal. Eur J Cancer. 2006;42(7):846–63. https://doi.org/10.1016/j.ejca.2005.11.026.CrossRefPubMed

11.

Mao JJ, Armstrong K, Bowman MA, Xie SX, Kadakia R, Farrar JT. Symptom burden among cancer survivors: impact of age and comorbidity. Journal of the American Board of Family Medicine : JABFM. 2007;20(5):434–43. https://doi.org/10.3122/jabfm.2007.05.060225.CrossRefPubMed

12.

Brebach R, Sharpe L, Costa DSJ, Rhodes P, Butow P. Psychological intervention targeting distress for cancer patients: a meta-analytic study investigating uptake and adherence. Psychooncology. 2016;25:882–90. https://doi.org/10.1002/pon.4099.CrossRefPubMed

13.

Boland L, Bennett K, Connolly D. Self-management interventions for cancer survivors: a systematic review. Support Care Cancer. 2018;26(5):1585–95. https://doi.org/10.1007/s00520-017-3999-7. CrossRefPubMed

14.

Carroll J, Moorhead A, Bond R, Leblanc W, Petrella R, Fiscella K. Who uses mobile phone health apps and does use matter? A secondary data analytics approach. J Med Internet Res. 2017;19(4):E125. https://doi.org/10.2196/jmir.5604.CrossRefPubMedPubMedCentral

15.

Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. https://doi.org/10.1371/journal.pmed.1000097.CrossRefPubMedPubMedCentral

16.

Adams KM, Corrigan J. Priority areas for national action : transforming health care quality. Washington, D.C.: National Academies Press; 2003.

17.

The Cochrane Collaboration. Assessing risk of bias in included studies. In: Higgins JPT AD, Sterne JAC, editor. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. Online: The Cochrane Collaboration; 2011.

18.

Kearney N, McCann L, Norrie J, Taylor L, Gray P, McGee-Lennon M, et al. Evaluation of a mobile phone-based, advanced symptom management system (ASyMS) in the management of chemotherapy-related toxicity. Support Care Cancer. 2009;17(4):437–44. https://doi.org/10.1007/s00520-008-0515-0.CrossRefPubMed

19.

Mayer DK, Landucci G, Awoyinka L, Atwood AK, Carmack CL, Demark-Wahnefried W, et al. SurvivorCHESS to increase physical activity in colon cancer survivors: can we get them moving? J Cancer Surviv. 2017;12:1–13. https://doi.org/10.1007/s11764-017-0647-7. CrossRef

20.

Uhm KE, Yoo JS, Chung SH, Lee JD, Lee I, Kim JI, et al. Effects of exercise intervention in breast cancer patients: is mobile health (mHealth) with pedometer more effective than conventional program using brochure? Breast Cancer Res Treat. 2017;161(3):443–52. https://doi.org/10.1007/s10549-016-4065-8.CrossRefPubMed

21.

Sundberg K, Wengstrom Y, Blomberg K, Halleberg-Nyman M, Frank C, Langius-Eklof A. Early detection and management of symptoms using an interactive smartphone application (Interaktor) during radiotherapy for prostate cancer. Support Care Cancer. 2017;25:2195–204. https://doi.org/10.1007/s00520-017-3625-8.CrossRefPubMedPubMedCentral

22.

Smith SK, Kuhn E, O'Donnell J, Koontz BF, Nelson N, Molloy K, et al. Cancer distress coach: pilot study of a mobile app for managing posttraumatic stress. Psychooncology. 2016. https://doi.org/10.1002/pon.4363.

23.

Fu MR, Axelrod D, Guth AA, Rampertaap K, El-Shammaa N, Hiotis K, et al. mHealth self-care interventions: managing symptoms following breast cancer treatment. Mhealth. 2016;2:28. https://doi.org/10.21037/mhealth.2016.07.03.CrossRefPubMedPubMedCentral

24.

Maguire R, Ream E, Richardson A, Connaghan J, Johnston B, Kotronoulas G, et al. Development of a novel remote patient monitoring system: the advanced symptom management system for radiotherapy to improve the symptom experience of patients with lung cancer receiving radiotherapy. Cancer Nurs. 2015;38(2):E37–47. https://doi.org/10.1097/NCC.0000000000000150.CrossRefPubMed

25.

Kessels E, Husson O, Van Der Feltz-Cornelis CM. The effect of exercise on cancer-related fatigue in cancer survivors: a systematic review and meta-analysis. Neuropsychiatr Dis Treat. 2018;Volume 14:479–94.CrossRef

26.

Langendijk JA, Aaronson NK, de Jong JM, ten Velde GP, Muller MJ, Lamers RJ, et al. Prospective study on quality of life before and after radical radiotherapy in non-small-cell lung cancer. J Clin Oncol. 2001;19(8):2123–33. https://doi.org/10.1200/JCO.2001.19.8.2123.CrossRefPubMed

27.

Gilbert B, Goodman E, Chadda A, Hatfield D, Forman D, Panch T. The role of mobile health in elderly populations. Current Geriatrics Reports. 2015;4(4):347–52. https://doi.org/10.1007/s13670-015-0145-6.CrossRef

28.

Abelson JS, Symer M, Peters A, Charlson M, Yeo H. Mobile health apps and recovery after surgery: what are patients willing to do? Am J Surg. 2017;214(4):616–22. https://doi.org/10.1016/j.amjsurg.2017.06.009.CrossRefPubMed

29.

Parry C, Kent EE, Mariotto AB, Alfano CM, Rowland JH. Cancer survivors: a booming population. Cancer Epidemiol Biomark Prev. 2011;20(10):1996. https://doi.org/10.1158/1055-9965.EPI-11-0729.CrossRef

30.

Rho M, Kim H, Chung K, Choi I. Factors influencing the acceptance of telemedicine for diabetes management. The Journal of Networks, Software Tools and Applications. 2015;18(1):321–31. https://doi.org/10.1007/s10586-014-0356-1.CrossRef

Title: The effectiveness of mHealth for self-management in improving pain, psychological distress, fatigue, and sleep in cancer survivors: a systematic review
Authors: Elizabeth Hernandez Silva
Sheleigh Lawler
Danette Langbecker
Publication date: 01-02-2019
Publisher: Springer US
Keyword: Fatigue
Published in: Journal of Cancer Survivorship / Issue 1/2019
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI: https://doi.org/10.1007/s11764-018-0730-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Implications for Cancer Survivors

Please log in to get access to this content

Other articles of this Issue 1/2019

Living with and beyond cancer with comorbid illness: a qualitative systematic review and evidence synthesis

Evaluation of a survivorship needs assessment planning tool for head and neck cancer survivor-caregiver dyads

Smoking cessation attitudes and practices among cancer survivors – United States, 2015

Factors associated with an adverse work outcome in breast cancer survivors 5–10 years after diagnosis: a cross-sectional study

Unpacking the layers: a meta-ethnography of cancer survivors’ loneliness

Development of the perceived barriers scale: a new instrument identifying barriers to career development and employment for young adult survivors of pediatric CNS tumors

Keynote webinar | Spotlight on antibody–drug conjugates in cancer